Deutsche Bank’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $13.2M | Buy |
125,451
+19,991
| +19% | +$1.77M | ﹤0.01% | 972 |
|
|
2025
Q4 | $9.21M | Sell |
105,460
-11,752
| -10% | -$962K | ﹤0.01% | 1106 |
|
|
2025
Q3 | $7.79M | Buy |
117,212
+6,048
| +5% | +$344K | ﹤0.01% | 1138 |
|
|
2025
Q2 | $6.14M | Buy |
111,164
+45,469
| +69% | +$2.18M | ﹤0.01% | 1158 |
|
|
2025
Q1 | $3.18M | Sell |
65,695
-72,237
| -52% | -$3.03M | ﹤0.01% | 1467 |
|
|
2024
Q4 | $5.32M | Buy |
137,932
+17,763
| +15% | +$774K | ﹤0.01% | 1303 |
|
|
2024
Q3 | $5.41M | Sell |
120,169
-788,179
| -87% | -$31.8M | ﹤0.01% | 1250 |
|
|
2024
Q2 | $31.5M | Sell |
908,348
-2,458
| -0.3% | -$72K | 0.01% | 688 |
|
|
2024
Q1 | $26.3M | Buy |
910,806
+794
| +0.1% | +$21.6K | 0.01% | 728 |
|
|
2023
Q4 | $20.9M | Buy |
910,012
+838,099
| +1,165% | +$14.7M | 0.01% | 792 |
|
|
2023
Q3 | $1.2M | Sell |
71,913
-789,411
| -92% | -$15.3M | ﹤0.01% | 1622 |
|
|
2023
Q2 | $23.8M | Sell |
861,324
-97,567
| -10% | -$2.44M | 0.01% | 717 |
|
|
2023
Q1 | $22.1M | Buy |
958,891
+33,229
| +4% | +$558K | 0.01% | 741 |
|
|
2022
Q4 | $10.1M | Buy |
925,662
+113,307
| +14% | +$956K | 0.01% | 959 |
|
|
2022
Q3 | $6.85M | Sell |
812,355
-5,477
| -0.7% | -$51.8K | ﹤0.01% | 1099 |
|
|
2022
Q2 | $6.47M | Sell |
817,832
-4,491
| -0.5% | -$54.3K | ﹤0.01% | 1173 |
|
|
2022
Q1 | $19.5M | Sell |
822,323
-2,549
| -0.3% | -$71.8K | 0.01% | 842 |
|
|
2021
Q4 | $28.2M | Buy |
824,872
+1,582
| +0.2% | +$50K | 0.01% | 762 |
|
|
2021
Q3 | $14.6M | Buy |
823,290
+1,568
| +0.2% | +$66.8K | 0.01% | 1007 |
|
|
2021
Q2 | $36.9M | Buy |
821,722
+796,161
| +3,115% | +$26.3M | 0.02% | 698 |
|
|
2021
Q1 | $662K | Buy |
25,561
+399
| +2% | +$10.1K | ﹤0.01% | 2911 |
|
|
2020
Q4 | $507K | Buy |
25,162
+8,789
| +54% | +$189K | ﹤0.01% | 2891 |
|
|
2020
Q3 | $320K | Buy |
16,373
+4,815
| +42% | +$90.4K | ﹤0.01% | 2930 |
|
|
2020
Q2 | $205K | Buy |
11,558
+5,440
| +89% | +$68.3K | ﹤0.01% | 3130 |
|
|
2020
Q1 | $43K | Sell |
6,118
-22,113
| -78% | -$166K | ﹤0.01% | 3621 |
|
|
2019
Q4 | $197K | Buy |
28,231
+8,015
| +40% | +$79.6K | ﹤0.01% | 3235 |
|
|
2019
Q3 | $241K | Sell |
20,216
-25,111
| -55% | -$316K | ﹤0.01% | 3078 |
|
|
2019
Q2 | $548K | Buy |
45,327
+13,333
| +42% | +$147K | ﹤0.01% | 3226 |
|
|
2019
Q1 | $401K | Buy |
31,994
+31,764
| +13,810% | +$280K | ﹤0.01% | 3580 |
|
|
2018
Q4 | $1K | Sell |
230
-201,980
| -100% | -$1.6M | ﹤0.01% | 5108 |
|
|
2018
Q3 | $2.08M | Sell |
202,210
-91,980
| -31% | -$792K | ﹤0.01% | 2827 |
|
|
2018
Q2 | $1.98M | Buy |
294,190
+279,174
| +1,859% | +$2.14M | ﹤0.01% | 2966 |
|
|
2018
Q1 | $128K | Sell |
15,016
-11,070
| -42% | -$208K | ﹤0.01% | 4400 |
|
|
2017
Q4 | $541K | Buy |
26,086
+17,416
| +201% | +$309K | ﹤0.01% | 3557 |
|
|
2017
Q3 | $152K | Sell |
8,670
-23,096
| -73% | -$320K | ﹤0.01% | 4007 |
|
|
2017
Q2 | $358K | Buy |
31,766
+25,210
| +385% | +$270K | ﹤0.01% | 3632 |
|
|
2017
Q1 | $83K | Buy |
6,556
+2,213
| +51% | +$35.7K | ﹤0.01% | 4000 |
|
|
2016
Q4 | $94K | Buy |
4,343
+3,073
| +242% | +$68.5K | ﹤0.01% | 4120 |
|
|
2016
Q3 | $26K | Buy |
+1,270
| New | +$17.4K | ﹤0.01% | 4457 |
|
Other funds holding PTGX
FCM
RI
VPM
VCM
JJ